K
Kay M. Tomashek
Researcher at National Institutes of Health
Publications - 111
Citations - 12468
Kay M. Tomashek is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Dengue fever & Dengue virus. The author has an hindex of 36, co-authored 103 publications receiving 9046 citations. Previous affiliations of Kay M. Tomashek include Centers for Disease Control and Prevention & University of California.
Papers
More filters
Journal ArticleDOI
Remdesivir for the Treatment of Covid-19 - Final Report.
John H. Beigel,Kay M. Tomashek,Lori E. Dodd,Aneesh K. Mehta,Barry S. Zingman,Andre C. Kalil,Elizabeth L. Hohmann,Helen Y. Chu,Annie Luetkemeyer,Susan Kline,Diego Lopez de Castilla,Robert W. Finberg,Kerry Dierberg,Victor F. Tapson,Lanny Hsieh,Thomas F. Patterson,Roger Paredes,Daniel A. Sweeney,William R. Short,Giota Touloumi,David Chien Lye,Norio Ohmagari,Myoung-don Oh,Guillermo M. Ruiz-Palacios,Thomas Benfield,Gerd Fätkenheuer,Mark G. Kortepeter,Robert L. Atmar,C. Buddy Creech,JD Lundgren,Abdel G. Babiker,Sarah Pett,James D. Neaton,Timothy Burgess,Tyler Bonnett,Michelle Green,Mat Makowski,Anu Osinusi,Seema U Nayak,H. Clifford Lane +39 more
TL;DR: The data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.
Journal ArticleDOI
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Andre C. Kalil,Thomas F. Patterson,Aneesh K. Mehta,Kay M. Tomashek,Cameron R. Wolfe,Varduhi Ghazaryan,Vincent C. Marconi,Guillermo M. Ruiz-Palacios,Lanny Hsieh,Susan Kline,Victor F. Tapson,Nicole M. Iovine,Mamta K. Jain,Daniel A. Sweeney,Hana M. El Sahly,Angela Branche,Justino Regalado Pineda,David C. Lye,Uriel Sandkovsky,Anne F Luetkemeyer,Stuart H. Cohen,Robert W. Finberg,Patrick E. H. Jackson,Babafemi Taiwo,Catharine I. Paules,Henry Arguinchona,Nathaniel B. Erdmann,Neera Ahuja,Maria G. Frank,Myoung Don Oh,Eu-Suk Kim,Seow Y Tan,Richard A. Mularski,Henrik Nielsen,Philip O Ponce,Barbara S. Taylor,LuAnn Larson,Nadine Rouphael,Youssef Saklawi,Valeria D Cantos,Emily R Ko,John J. Engemann,Alpesh Amin,Miki Watanabe,Joanne Billings,Marie-Carmelle Elie,Richard T. Davey,Timothy Burgess,Jennifer Ferreira,Michelle Green,Mat Makowski,Anabela Cardoso,Stephanie de Bono,Tyler Bonnett,Michael A. Proschan,Gregory A. Deye,Walla Dempsey,Seema U Nayak,Lori E. Dodd,John H. Beigel +59 more
TL;DR: Baricitinib plus remdesivir was superior to remdes Vivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation.
Journal ArticleDOI
“Late-Preterm” Infants: A Population at Risk
TL;DR: The characteristics of late-preterm infants are presented, a change in terminology from “near term” to “late preterm,” and guidelines for the evaluation and management of these infants after birth are proposed.
Journal Article
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
W. Lledo,M. Hernandez,E. Lopez,O. L. Molinari,Raimundo Soto,E. Hernandez,N. Santiago,M. Flores,G. J. Vazquez,I. E. Robledo,E. Garcia-Rivera,Ana Cortés,M. Ramos,Richard V. Goering,Arjun Srinivasan,Carolyn V. Gould,N. Stine,Michael Bell,K. Anderson,B. Kitchel,Betty Wong,J. K. Rasheed,Janak H. Patel,Kay M. Tomashek,E. Llata +24 more
TL;DR: In this paper, the authors provide updated recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) for the control of CRE or carbapenemase-producing Enterobacteriaceae in acute care (inpatient) facilities.
Journal ArticleDOI
Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk.
Carrie K. Shapiro-Mendoza,Kay M. Tomashek,Milton Kotelchuck,Wanda D. Barfield,Angela Nannini,Judith Weiss,Eugene Declercq +6 more
TL;DR: Late-preterm infants who were born to mothers with any of the maternal conditions assessed were at higher risk for newborn morbidity compared with similarly exposed term infants, and those exposed to antepartum hemorrhage and hypertensive disorders of pregnancy were especially vulnerable.